RA Capital Healthcare Fund LP

Track

Insider profile

RA Capital Healthcare Fund LP's trades of Fulcrum Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-08 2025-12-08
PrS Proposed sale
27,389
35.14
US$1,554,615 		27,389 35.14 US$1,554,615
2025-11-21 2025-11-21
PrS Proposed sale
56,272
442.40
US$3,961,896 		56,272 442.40 US$3,961,896
2025-11-20 2025-11-20
PrS Proposed sale
81,856
483.49
US$2,146,539 		81,856 483.49 US$2,146,539
2025-11-19 2025-11-19
PrS Proposed sale
2,278
39.12
US$89,115 		2,278 39.12 US$89,115
2025-11-18 2025-11-18
PrS Proposed sale
332
39.04
US$12,961 		332 39.04 US$12,961
2025-11-17 2025-11-17
PrS Proposed sale
3,936
39.93
US$157,164 		3,936 39.93 US$157,164
2025-10-28 2025-10-28
PrS Proposed sale
3,624
39.45
US$142,967 		3,624 39.45 US$142,967
2025-10-24 2025-10-24
PrS Proposed sale
14,116
39.21
US$553,488 		14,116 39.21 US$553,488
2025-10-20 2025-10-20
PrS Proposed sale
76,919
29.43
US$2,263,726 		76,919 29.43 US$2,263,726
2025-10-17 2025-10-17
PrS Proposed sale
218,043
29.00
US$6,323,247 		218,043 29.00 US$6,323,247
2025-10-16 2025-10-16
PrS Proposed sale
126,887
29.06
US$3,687,336 		126,887 29.06 US$3,687,336
2025-10-15 2025-10-15
PrS Proposed sale
42,933
30.22
US$1,297,435 		42,933 30.22 US$1,297,435
2024-08-15 2024-08-15
PrS Proposed sale
1,699,998
1.00
US$1,699,999 		1,699,998 1.00 US$1,699,999
2023-12-18 2023-12-18
PrS Proposed sale
1,765,788
0.94
US$1,666,551 		1,765,788 0.94 US$1,666,551
2023-12-12 2023-12-12
PrS Proposed sale
220,738
0.90
US$198,664 		220,738 0.90 US$198,664
2023-11-27 2023-11-27
PrS Proposed sale
906,504
1.29
US$1,169,390 		906,504 1.29 US$1,169,390
2023-11-21 2023-11-21
PrS Proposed sale
471,732
2.06
US$971,767 		471,732 2.06 US$971,767